Janelidze et al. (2015), measured CSF neurogranin and YKL-40 levels in a cohort of 338 individuals including cognitively healthy controls and patients with sporadic MCI, MCI which later developed AD, PD, DLB, VaD, and FTD patients. Here, NRGN is linked to Parkinson disease.